SCHEMBL5487082

SCHEMBL5487082

Nc1ncc2ncccn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
PKM P14618 2/20 0.37
MAP2K2 P36507 3/20 0.36
CLK4 Q9HAZ1 3/20 0.36
NTRK1 P04629 2/20 0.36
LTK P29376 2/20 0.36
RPS6KA3 P51812 2/20 0.36
PRKX P51817 2/20 0.36
PRKCQ Q04759 2/20 0.36
FGFR1 P11362 2/20 0.36
MAPK9 P45984 2/20 0.36
IGF1R P08069 1/20 0.36
TNK2 Q07912 1/20 0.36
BACE1 P56817 2/20 0.35
HSP90AA1 P07900 1/20 0.35
DYRK1A Q13627 3/20 0.32
PRKACA P17612 3/20 0.32
KDR P35968 3/20 0.32
CDK8 P49336 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12920656 0.74 ADORA3 (0.38) SMPD3ADORA3PKMCLK4BACE1
SCHEMBL21388571 0.74 ADORA3 (0.35) SMPD3ADORA3PKMBACE1DYRK1A
SCHEMBL400723 0.71 CLK4 (0.44) ADORA3MAP2K2CLK4NTRK1LTK
SCHEMBL5487220 0.70 ADORA3 (0.42) SMPD3ADORA3PKMCLK4BACE1
SCHEMBL14048219 0.69 PDE10A (0.37) ADORA3CLK4BACE1DYRK1APRKACA
SCHEMBL12604060 0.69 ADORA3 (0.35) ADORA3CLK4BACE1DYRK1APRKACA
SCHEMBL15935242 0.69 ADORA3 (0.35) ADORA3CLK4BACE1DYRK1APRKACA
SCHEMBL399440 0.68 CHEK1 (0.32) DYRK1APRKACAKDRCDK8MAP2K1
SCHEMBL18879011 0.67 PKM (0.41) SMPD3PKMFGFR1BACE1HSP90AA1
SCHEMBL334476 0.65 KDM4E (0.55) PKMMAP2K2CLK4NTRK1LTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7306631-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-12-11 US disclosed
EP-1732509-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION The Procter and Gamble Company (US) 2006-12-20 EP disclosed
WO-2005097052-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION THE PROCTER & GAMBLE COMPANY (US) 2005-10-20 WO disclosed
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, JUP SMPD3 4766/4885ADORA3 4765/4885PKM 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.